After the method development part, the assay was validated by performing incubations in which the inhibiting effect of the control inhibitor ticlopidine at different concentrations (0, 0.03, 0.1, 0.3, 1, 3 and 10 μM) on the HLM-mediated efavirenz metabolism was investigated.
After the method development part, the assay was validated by performing incubations in which the inhibiting effect of the control inhibitor ticlopidine at different concentrations (0, 0.03, 0.1, 0.3, 1, 3 and 10 μM) on the HLM-mediated efavirenz metabolism was investigated.
正在翻译中..